Trials / Sponsors / GT Biopharma, Inc.
GT Biopharma, Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies High-risk Myelodysplastic Syndromes, Acute Myelogenous Leukemia, Systemic Mastocytosis | Phase 1 / Phase 2 | 2020-01-01 |